Kimberly-Clark, the American company behind Kleenex tissues and Huggies nappies, is set to acquire Kenvue, the maker of Tylenol and other household brands in a cash-and-stock deal valued at more than $40 bn (£30.5 bn). The merger would form a global consumer goods powerhouse with some of the most recognisable bathroom and medicine cabinet staples in the world.
Creating a Consumer Health Powerhouse
Kenvue, which also owns brands such as Band-Aid, Zyrtec, Benadryl, Neutrogena and Aveeno, has struggled since its spin-off from Johnson & Johnson in 2023. The separation was intended to give both companies sharper focus, but...